Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 2086-2091 |
Aantal pagina's | 6 |
Tijdschrift | Leukemia |
Volume | 35 |
Nummer van het tijdschrift | 7 |
DOI's | |
Status | Gepubliceerd - jul. 2021 |
Toegang tot document
Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Leukemia, Vol. 35, Nr. 7, 07.2021, blz. 2086-2091.
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
TY - JOUR
T1 - HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia
AU - de Barrios, Oriol
AU - Galaras, Alexandros
AU - Trincado, Juan L.
AU - Azagra, Alba
AU - Collazo, Olga
AU - Meler, Ainara
AU - Agraz-Doblas, Antonio
AU - Bueno, Clara
AU - Ballerini, Paola
AU - Cazzaniga, Giovanni
AU - Stam, Ronald W.
AU - Varela, Ignacio
AU - De Lorenzo, Paola
AU - Valsecchi, Maria Grazia
AU - Hatzis, Pantelis
AU - Menéndez, Pablo
AU - Parra, Maribel
N1 - Funding Information: Acknowledgements The authors wish to thank all clinical and laboratory members of the Interfant treatment protocol for their support and accessibility of samples/clinical data. We thank CERCA Programme/Generalitat de Catalunya for institutional support. This paper was funded by grants to MP by the Spanish Ministry of Science, Innovation and Universities (SAF2017-87990-R and EUR2019-103835) and elaborated at the Josep Carreras Leukaemia Research Institute (IJC, Badalona, Barcelona) and IDIBELL Research Institute (L’Hospitalet de Llobregat, Barcelona). OdB is funded by a Juan de la Cierva—Formación fellowship from the Spanish Ministry of Science, Innovation and Universities (FJCI-2017-32430). AM is funded by the Spanish Ministry of Science, Innovation and Universities, which is part of the Agencia Estatal de Investigación (AEI), through grant PRE2018-083183 (cofunded by the European Social Fund). Work in PM and CB’s lab was supported by the European Research Council (CoG-2014646903), the Spanish Ministry of Economy and Competitiveness (SAF-2016-80481-R), Uno entre Cien Mil Foundation, the Leo Messi Foundation, the Asociación Española Contra el Cáncer (AECC-CI-2015), and the ISCIII/FEDER (PI17/01028). We thank Juan Ramón Tejedor for the analysis of ChIP sequencing data.
PY - 2021/7
Y1 - 2021/7
UR - http://www.scopus.com/inward/record.url?scp=85096982699&partnerID=8YFLogxK
U2 - 10.1038/s41375-020-01097-x
DO - 10.1038/s41375-020-01097-x
M3 - Article
C2 - 33262526
AN - SCOPUS:85096982699
SN - 0887-6924
VL - 35
SP - 2086
EP - 2091
JO - Leukemia
JF - Leukemia
IS - 7
ER -